TrialBlood2024

Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial.

Steven W Pipe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.